Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
Open accessAbstract
Replicated international studies have underscored the human and societal costs associated with major depressive disorder. Despite the proven efficacy of monoamine-based antidepressants in major depression, the majority of treated individuals fail to achieve full syndromal and functional recovery with the index and subsequent pharmacological treatments. Ketamine and esketamine represent pharmacologically novel treatment avenues for adults with treatment-resistant depression. In addition to providing hope to affected persons, these agents represent the first non-monoaminergic agents with proven rapid-onset efficacy in major depressive disorder. Nevertheless, concerns remain about the safety and tolerability of ketamine and esketamine in mood disorders. Moreover, there is uncertainty about the appropriate position of these agents in treatment algorithms, their comparative effectiveness, and the appropriate setting, infrastructure, and personnel required for their competent and safe implementation. In this article, an international group of mood disorder experts provides a synthesis of the literature with respect to the efficacy, safety, and tolerability of ketamine and esketamine in adults with treatment-resistant depression. The authors also provide guidance for the implementation of these agents in clinical practice, with particular attention to practice parameters at point of care. Areas of consensus and future research vistas are discussed.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Available evidence indicates that the efficacy of ketamine/esketamine in the acute treatment of TRD is also apparent in individuals with greater degrees of antidepressant resistance.
“Available evidence also indicates that the efficacy of ketamine/esketamine in the acute treat ment of TRD is also apparent in individuals with greater de grees of antidepressant resistance 205 .”
From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [205]
The ‘Ketamine and Esketamine Efficacy in TRD’ section reports short-term efficacy for both treatments in adults with TRD. But ‘Patient Selection’ says ketamine’s efficacy may be attenuated with greater treatment resistance in some studies, while whether esketamine’s efficacy is attenuated is unknown. The source therefore does not establish the claim as stated for both treatments in more highly resistant patients. (LLM, conf=0.84)
Experimental — accuracy not yet measuredThe risks for the foregoing safety concerns would be expected to be mitigated when administering ketamine/esketamine under medical supervision in accordance with best practices.
“The risks for the foregoing safety concerns would be expected to be mitigated when administering ketamine/esketamine under medical supervision in accordance with best practices 205 .”
From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [205]
A recent review of literature emphasises that tolerance of ketamine is good.
“This result is in line with a recent review of literature emphasising that tolerance of ketamine is good.32”
From Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial (2022) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,501 · see citing works
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793 · see citing works
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750 · see citing works
Self-citationSynaptic Dysfunction in Depression: Potential Therapeutic Targets
Duman, R. S., & Aghajanian, G. K. (2012) · Science · doi:10.1126/science.1222939 · Cited by 1,651 · see citing works
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., et al. (2016) · Nature · doi:10.1038/nature17998 · Cited by 1,609 · see citing works
Self-citationKetamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015198 · Cited by 1,260 · see citing works
Self-citationMechanisms of ketamine action as an antidepressant
Zanos, P., & Gould, T. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.255 · Cited by 1,127 · see citing works
Maeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103 · see citing works
Self-citationMcIntyre, R. S., Berk, M., Brietzke, E., Goldstein, B. I., López-Jaramillo, C., Kessing, L. V., Malhi, G. S., Nierenberg, A. A., Rosenblat, J. D., Majeed, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31544-0 · Cited by 1,047 · see citing works
Self-citationDiazgranados, N., Ibrahim, L., Brutsche, N. E., Newberg, A., Kronstein, P., Khalife, S., Kammerer, W. A., Quezado, Z., Luckenbaugh, D. A., Salvadore, G., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.90 · Cited by 963 · see citing works
Self-citationPopova, V., Daly, E. J., Trivedi, M., Cooper, K., Lane, R., Lim, P., Mazzucco, C., Hough, D., Thase, M. E., Shelton, R. C., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19020172 · Cited by 904 · see citing works
Self-citationDaly, E. J., Trivedi, M. H., Janik, A., Li, H., Zhang, Y., Li, X., Lane, R., Lim, P., Duca, A. R., Hough, D., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.1189 · Cited by 795 · cited 2× · see citing works
“Intranasal esketamine combined with a conventional antidepressant decreased the risk of relapse by 51% among personswhohad achieved stable remission and 70% among those who achieved a stable responsewithacute therapy (60).”
BackgroundSelf-citationMurrough, J. W., Perez, A. M., Pillemer, S., Stern, J., Parides, M. K., aan het Rot, M., Collins, K. A., Mathew, S. J., Charney, D. S., & Iosifescu, D. V. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.022 · Cited by 786 · see citing works
Self-citationMcIntyre, R. S., Cha, D. S., Soczynska, J. K., Woldeyohannes, H. O., Gallaugher, L. A., Kudlow, P., Alsuwaidan, M., & Baskaran, A. (2013) · Depression and Anxiety · doi:10.1002/da.22063 · Cited by 765 · see citing works
Self-citationWilkinson, S. T., Ballard, E. D., Bloch, M. H., Mathew, S. J., Murrough, J. W., Feder, A., Sos, P., Wang, G., Zarate, C. A., & Sanacora, G. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17040472 · Cited by 696 · see citing works
Self-citationMalhotra, A. K. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00036-5 · Cited by 681 · see citing works
Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
Peltoniemi, M. A., Hagelberg, N. M., Olkkola, K. T., & Saari, T. I. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0383-6 · Cited by 672 · see citing works
Feder, A., Parides, M. K., Murrough, J. W., Perez, A. M., Morgan, J. E., Saxena, S., Kirkwood, K., aan het Rot, M., Lapidus, K. A. B., Wan, L.-B., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.62 · Cited by 613 · see citing works
Self-citationFedgchin, M., Trivedi, M., Daly, E. J., Melkote, R., Lane, R., Lim, P., Vitagliano, D., Blier, P., Fava, M., Liebowitz, M., et al. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz039 · Cited by 606 · see citing works
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
Sanacora, G., Frye, M. A., McDonald, W., Mathew, S. J., Turner, M. S., Schatzberg, A. F., Summergrad, P., Nemeroff, C. B., & for the American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0080 · Cited by 576 · see citing works
Self-citationSide-effects associated with ketamine use in depression: a systematic review
Short, B., Fong, J., Galvez, V., Shelker, W., & Loo, C. K. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30272-9 · Cited by 558 · see citing works
Singh, J. B., Fedgchin, M., Daly, E. J., De Boer, P., Cooper, K., Lim, P., Pinter, C., Murrough, J. W., Sanacora, G., Shelton, R. C., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16010037 · Cited by 525 · see citing works
Self-citationAttenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
Williams, N. R., Heifets, B. D., Blasey, C., Sudheimer, K., Pannu, J., Pankow, H., Hawkins, J., Birnbaum, J., Lyons, D. M., Rodriguez, C. I., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18020138 · Cited by 519 · see citing works
Ochs-Ross, R., Daly, E. J., Zhang, Y., Lane, R., Lim, P., Morrison, R. L., Hough, D., Manji, H., Drevets, W. C., Sanacora, G., et al. (2020) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.10.008 · Cited by 481 · see citing works
Self-citationA Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
Lapidus, K. A. B., Levitch, C. F., Perez, A. M., Brallier, J. W., Parides, M. K., Soleimani, L., Feder, A., Iosifescu, D. V., Charney, D. S., & Murrough, J. W. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.03.026 · Cited by 480 · see citing works
Self-citationFava, M., Freeman, M. P., Flynn, M., Judge, H., Hoeppner, B. B., Cusin, C., Ionescu, D. F., Mathew, S. J., Chang, L. C., Iosifescu, D. V., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0256-5 · Cited by 433 · see citing works
Self-citationAnand, A., Charney, D. S., Oren, D. A., Berman, R. M., Hu, X. S., Cappiello, A., & Krystal, J. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.270 · Cited by 426 · see citing works
Ionescu, D. F., Fu, D.-J., Qiu, X., Lane, R., Lim, P., Kasper, S., Hough, D., Drevets, W. C., Manji, H., & Canuso, C. M. (2021) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa068 · Cited by 418 · see citing works
Self-citationLee, Y. L., Ragguett, R., Mansur, R. B., Boutilier, J. J., Rosenblat, J. D., Trevizol, A. P., Brietzke, E. M., Lin, K., Pan, Z., Subramaniapillai, M., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.08.073 · Cited by 411 · see citing works
Self-citationBahji, A., Vazquez, G. H., & Zarate, C. A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.071 · Cited by 408 · see citing works
Self-citationRandomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept
Rodriguez, C. I., Kegeles, L. S., Levinson, A., Feng, T., Marcus, S. M., Vermes, D., Flood, P., & Simpson, H. B. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.150 · Cited by 386 · see citing works
Fu, D.-J., Ionescu, D. F., Li, X., Lane, R., Lim, P., Sanacora, G., Hough, D., Manji, H., Drevets, W. C., & Canuso, C. M. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19m13191 · Cited by 376 · see citing works
Self-citationKetamine-Associated Ulcerative Cystitis: A New Clinical Entity
Shahani, R., Streutker, C. J., Dickson, B. C., & Stewart, R. J. (2007) · Urology · doi:10.1016/j.urology.2007.01.038 · Cited by 375 · see citing works
Morgan, C. J. A., Muetzelfeldt, L., & Curran, H. V. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02761.x · Cited by 373 · see citing works
Vollenweider, F. X., Leenders, K. L., Scharfetter, C., Antonini, A., Maguire, P., Missimer, J., & Angst, J. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(96)00039-9 · Cited by 353 · see citing works
Ibrahim, L., DiazGranados, N., Franco-Chaves, J., Brutsche, N., Henter, I. D., Kronstein, P., Moaddel, R., Wainer, I., Luckenbaugh, D. A., Manji, H. K., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.338 · Cited by 309 · see citing works
Self-citationAcute and chronic effects of ketamine upon human memory: a review
Morgan, C. J. A., & Curran, H. V. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0572-3 · Cited by 304 · see citing works
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression
Wajs, E., Aluisio, L., Holder, R., Daly, E. J., Lane, R., Lim, P., George, J. E., Morrison, R. L., Sanacora, G., Young, A. H., et al. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19m12891 · Cited by 299 · cited 3× · see citing works
“It is reassuring that a long-term study with intranasal esketamine did not identify a significant percentage of individuals experiencing genitourinary symptoms (100, 101).”
BackgroundSelf-citationKetamine for rapid reduction of suicidal ideation: a randomized controlled trial
Murrough, J. W., Soleimani, L., DeWilde, K. E., Collins, K. A., Lapidus, K. A., Iacoviello, B. M., Lener, M., Kautz, M., Kim, J., Stern, J. B., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715001506 · Cited by 297 · see citing works
Self-citationMathew, S. J., Murrough, J. W., Rot, M. A. H., Collins, K. A., Reich, D. L., & Charney, D. S. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000169 · Cited by 296 · see citing works
Self-citationDo the dissociative side effects of ketamine mediate its antidepressant effects?
Luckenbaugh, D. A., Niciu, M. J., Ionescu, D. F., Nolan, N. M., Richards, E. M., Brutsche, N. E., Guevara, S., & Zarate, C. A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.017 · Cited by 283 · see citing works
Self-citationMcAllister-Williams, R. H., Arango, C., Blier, P., Demyttenaere, K., Falkai, P., Gorwood, P., Hopwood, M., Javed, A., Kasper, S., Malhi, G. S., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.02.023 · Cited by 278 · see citing works
Self-citationLoo, C. K. A., Gálvez, V., O’Keefe, E. J., Mitchell, P. B., Hadzi‐Pavlovic, D., Leyden, J., Harper, S., Somogyi, A. A., Lai, R., Weickert, C. S., et al. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12572 · Cited by 258 · see citing works
The prevalence and natural history of urinary symptoms among recreational ketamine users
WINSTOCK, A. R., Mitcheson, L., Gillatt, D. A., & Cottrell, A. M. (2012) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.11028.x · Cited by 217 · see citing works
Witt, K., Potts, J., Hubers, A., Grunebaum, M. F., Murrough, J. W., Loo, C., Cipriani, A., & Hawton, K. (2020) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419883341 · Cited by 202 · see citing works
Self-citationCorreia-Melo, F. S., Leal, G. C., Vieira, F., Jesus-Nunes, A. P., Mello, R. P., Magnavita, G., Caliman-Fontes, A. T., Echegaray, M. V. F., Bandeira, I. D., Silva, S. S., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.086 · Cited by 193 · see citing works
Ibrahim, L. A., Diazgranados, N., Luckenbaugh, D. A., Machado‐Vieira, R., Baumann, J., Mallinger, A. G., & Zarate, C. A. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.019 · Cited by 191 · see citing works
Self-citationThe effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis
McIntyre, R. S., Carvalho, I. P., Lui, L. M. W., Majeed, A., Masand, P. S., Gill, H., Rodrigues, N. B., Lipsitz, O., Coles, A. C., Lee, Y., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.06.050 · Cited by 187 · see citing works
Self-citationDakwar, E., Nunes, E. V., Hart, C. L., Foltin, R. W., Mathew, S. J., Carpenter, K. M., Choi, C. J. “., Basaraba, C. N., Pavlicova, M., & Levin, F. R. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18101123 · Cited by 186 · see citing works
Perlman, K., Benrimoh, D. A., Israel, S. A., Rollins, C. P. E., Brown, E. H., Tunteng, J.-F., You, R., You, E. L., Tanguay-Sela, M., Snook, E., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.09.067 · Cited by 185 · see citing works
Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin
Abdallah, C. G., Averill, L. A., Gueorguieva, R., Goktas, S., Purohit, P., Ranganathan, M., Sherif, M., Ahn, K.-H., D’Souza, D. C., Formica, R., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0644-9 · Cited by 184 · see citing works
Self-citationDakwar, E., Levin, F., Hart, C. L., Basaraba, C., Choi, J., Pavlicova, M., & Nunes, E. V. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19070684 · Cited by 183 · see citing works
Rosenblat, J. D., & McIntyre, R. S. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.10.042 · Cited by 179 · see citing works
Self-citationIonescu, D. F., Bentley, K. H., Eikermann, M., Taylor, N., Akeju, O., Swee, M. B., Pavone, K. J., Petrie, S. R., Dording, C., Mischoulon, D., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.09.037 · Cited by 179 · see citing works
Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism
Williams, N. R., Heifets, B. D., Bentzley, B. S., Blasey, C., Sudheimer, K. D., Hawkins, J., Lyons, D. M., & Schatzberg, A. F. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0503-4 · Cited by 174 · see citing works
The Mu-Opioid Receptor and the NMDA Receptor Associate in PAG Neurons: Implications in Pain Control
Rodríguez-Muñoz, M., Sánchez‐Blázquez, P., Vicente‐Sánchez, A., Berrocoso, E., & Garzón, J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.155 · Cited by 170 · see citing works
Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
Niciu, M. J., Luckenbaugh, D. A., Ionescu, D. F., Guevara, S., Machado-Vieira, R., Richards, E. M., Brutsche, N. E., Nolan, N. M., & Zarate, C. A. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08698 · Cited by 165 · see citing works
Self-citationSanacora, G., & Schatzberg, A. F. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.261 · Cited by 160 · see citing works
Self-citationKryst, J., Kawalec, P., Mitoraj, A. M., Pilc, A., Lasoń, W., & Brzostek, T. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00097-z · Cited by 159 · see citing works
Lumsden, E. W., Troppoli, T. A., Myers, S. J., Zanos, P., Aracava, Y., Kehr, J., Lovett, J., Kim, S., Wang, F.-H., Schmidt, S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1816071116 · Cited by 158 · see citing works
Self-citationEsketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval
Turner, E. H. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30394-3 · Cited by 156 · see citing works
Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents
Klein, M. E., Chandra, J., Sheriff, S., & Malinow, R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916570117 · Cited by 156 · see citing works
Yoon, G., Petrakis, I. L., & Krystal, J. H. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3990 · Cited by 155 · see citing works
Bartova, L., Dold, M., Kautzky, A., Fabbri, C., Spies, M., Serretti, A., Souery, D., Mendlewicz, J., Zohar, J., Montgomery, S., et al. (2019) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2019.1635270 · Cited by 152 · see citing works
Self-citationEsketamine for treatment resistant depression
Swainson, J., Thomas, R. K., Archer, S., Chrenek, C., MacKay, M.-A., Baker, G., Dursun, S., Klassen, L. J., Chokka, P., & Demas, M. L. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1640604 · Cited by 151 · see citing works
Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials
Ballard, E. D., Wills, K. E., Lally, N., Richards, E. M., Luckenbaugh, D. A., Walls, T. L., Ameli, R., Niciu, M. J., Brutsché, N. E., Park, L., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.04.057 · Cited by 146 · see citing works
Self-citationLow-Dose Naltrexone (LDN)—Review of Therapeutic Utilization
Toljan, K., & Vrooman, B. (2018) · Medical Sciences · doi:10.3390/medsci6040082 · Cited by 146 · see citing works
Murrough, J. W., Burdick, K. E., Levitch, C. F., Perez, A. M., Brallier, J. W., Chang, L. C., Foulkes, A., Charney, D. S., Mathew, S. J., & Iosifescu, D. V. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.298 · Cited by 142 · see citing works
Self-citationPhillips, J. L., Norris, S., Talbot, J., Hatchard, T., Ortiz, A., Birmingham, M., Owoeye, O., Batten, L. A., & Blier, P. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0570-x · Cited by 139 · see citing works
Zhao, X., Venkata, S. L. V., Moaddel, R., Luckenbaugh, D. A., Brutsche, N. E., Ibrahim, L., Zarate Jr, C. A., Mager, D. E., & Wainer, I. W. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04198.x · Cited by 137 · see citing works
Gastaldon, C., Raschi, E., Kane, J. M., Barbui, C., & Schoretsanitis, G. (2021) · Psychotherapy and Psychosomatics · doi:10.1159/000510703 · Cited by 134 · see citing works
Niciu, M. J., Shovestul, B. J., Jaso, B. A., Farmer, C., Luckenbaugh, D. A., Brutsché, N. E., Park, L. T., Ballard, E. D., & Zarate, C. A. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.02.049 · Cited by 133 · see citing works
Self-citationvan Bronswijk, S., Moopen, N., Beijers, L., Ruhe, H. G., & Peeters, F. (2019) · Psychological Medicine · doi:10.1017/s003329171800199x · Cited by 128 · see citing works
Neuroimaging-based biomarkers for treatment selection in major depressive disorder
Dunlop, B. W., & Mayberg, H. S. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.4/bdunlop · Cited by 127 · see citing works
A Survey of the Clinical, Off-Label Use of Ketamine as a Treatment for Psychiatric Disorders
Wilkinson, S. T., Toprak, M., Turner, M. S., Levine, S. P., Katz, R. B., & Sanacora, G. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17020239 · Cited by 125 · see citing works
Self-citationXiong, J., Lipsitz, O., Chen-Li, D., Rosenblat, J. D., Rodrigues, N. B., Carvalho, I., Lui, L. M. W., Gill, H., Narsi, F., Mansur, R. B., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.12.038 · Cited by 124 · see citing works
Self-citationWilkinson, S. T., Wright, D., Fasula, M. K., Fenton, L. R., Griepp, M., Ostroff, R. B., & Sanacora, G. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000457960 · Cited by 122 · see citing works
Self-citationMontgomery, S. A., & Möller, H.-J. (2009) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32832a8eb2 · Cited by 121 · see citing works
Alexander, L., Gaskin, P. L. R., Sawiak, S. J., Fryer, T. D., Hong, Y. T., Cockcroft, G. J., Clarke, H. F., & Roberts, A. C. (2019) · Neuron · doi:10.1016/j.neuron.2018.11.021 · Cited by 120 · see citing works
Rong, C., Park, C., Rosenblat, J. D., Subramaniapillai, M., Zuckerman, H., Fus, D., Lee, Y. L., Pan, Z., Brietzke, E., Mansur, R. B., et al. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15040771 · Cited by 114 · see citing works
Self-citationRosenblat, J. D., Carvalho, A. F., Li, M., Lee, Y. L., Subramanieapillai, M., & McIntyre, R. S. (2019) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.18r12475 · Cited by 114 · see citing works
Self-citationMurrough, J. W., Wan, L.-B., Iacoviello, B. M., Collins, K. A., SOLON, C. A., Glicksberg, B. S., Perez, A. M., Mathew, S. J., Charney, D. S., Iosifescu, D. V., et al. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3255-x · Cited by 112 · see citing works
Self-citationCusin, C., Ionescu, D. F., Pavone, K. J., Akeju, O., Cassano, P., Taylor, N. E., Eikermann, M., Durham, K. E., Swee, M. B., Chang, T. E., et al. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416631828 · Cited by 111 · see citing works
McIntyre, R. S., Rodrigues, N. B., Lee, Y., Lipsitz, O., Subramaniapillai, M., Gill, H., Nasri, F., Majeed, A., Lui, L. M. W., Senyk, O., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.05.088 · Cited by 110 · see citing works
Self-citationEfficacy of Esketamine Augmentation in Major Depressive Disorder: A Meta-Analysis
Papakostas, G. I., Salloum, N. C., Hock, R. S., Jha, M. K., Murrough, J. W., Mathew, S. J., Iosifescu, D. V., & Fava, M. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19r12889 · Cited by 108 · see citing works
Self-citationPossible pathophysiology of ketamine‐related cystitis and associated treatment strategies
Jhang, J., Hsu, Y., & Kuo, H. (2015) · International Journal of Urology · doi:10.1111/iju.12841 · Cited by 106 · see citing works
Morgan, C. J. A., Mofeez, A., Brandner, B., Bromley, L. M., & Curran, H. V. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1656-y · Cited by 106 · see citing works
Ketamine normalizes subgenual cingulate cortex hyper-activity in depression
Morris, L. S., Costi, S., Tan, A., Stern, E. R., Charney, D. S., & Murrough, J. W. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0591-5 · Cited by 104 · see citing works
Self-citationA Word to the Wise About Ketamine
Schatzberg, A. F. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13101434 · Cited by 102 · see citing works
A Word to the Wise About Intranasal Esketamine
Schatzberg, A. F. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19040423 · Cited by 96 · see citing works
Greenway, K. T., Garel, N., Jerome, L., & Feduccia, A. A. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1772054 · Cited by 94 · see citing works
Gill, H., Gill, B., Rodrigues, N. B., Lipsitz, O., Rosenblat, J. D., El-Halabi, S., Nasri, F., Mansur, R. B., Lee, Y., & McIntyre, R. S. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.11.020 · Cited by 93 · see citing works
Self-citationDomany, Y., Shelton, R. C., & McCullumsmith, C. B. (2020) · Depression and Anxiety · doi:10.1002/da.22975 · Cited by 84 · see citing works
Treating to target in major depressive disorder: response to remission to functional recovery
McIntyre, R. S., Lee, Y. L., & Mansur, R. B. (2015) · CNS Spectrums · doi:10.1017/s1092852915000826 · Cited by 83 · see citing works
Self-citationZhang, Y., Zhang, T., Guo, C., Lv, J., Hua, Z., Hou, S., Zhang, Y., Meng, W., & Xu, J. F. (2016) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2016.11.101 · Cited by 78 · see citing works
van Schalkwyk, G. I., Wilkinson, S. T., Davidson, L., Silverman, W. K., & Sanacora, G. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.09.023 · Cited by 77 · see citing works
Self-citationAttentional bias to incentive stimuli in frequent ketamine users
Morgan, C. J. A., Rees, H., & Curran, H. V. (2008) · Psychological Medicine · doi:10.1017/s0033291707002450 · Cited by 76 · see citing works
Improving Depression Outcome by Patient-Centered Medical Management
Rush, A. J., & Thase, M. E. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18040398 · Cited by 76 · see citing works
Self-citationFrye, M. A., Blier, P., & Tye, S. J. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000316 · Cited by 75 · see citing works
A New Perspective on the Anti-Suicide Effects With Ketamine Treatment: A Procognitive Effect
Lee, Y., Syeda, K., Maruschak, N. A., Cha, D. S., Mansur, R. B., Wium-Andersen, I. K., Woldeyohannes, H. O., Rosenblat, J. D., & McIntyre, R. S. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000441 · Cited by 74 · see citing works
Self-citationMorrison, R. L., Fedgchin, M. M., Singh, J. B., van Gerven, J., Zuiker, R. G. J. A., Lim, K. S., van der Ark, P. D., Wajs, E., Xi, L., Zannikos, P., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4828-5 · Cited by 73 · see citing works
Gilbert, J. R., & Zarate, C. A. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172856 · Cited by 71 · see citing works
Self-citationProtti, M., Mandrioli, R., Marasca, C., Cavalli, A., Serretti, A., & Mercolini, L. (2020) · Medicinal Research Reviews · doi:10.1002/med.21671 · Cited by 71 · see citing works
Ravikrishnan, A., Gandhi, P. J., Shelkar, G. P., Liu, J., Pavuluri, R., & Dravid, S. M. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.03.011 · Cited by 70 · see citing works
Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions
Riva-Posse, P., Reiff, C. M., Edwards, J. A., Job, G. P., Galendez, G. C., Garlow, S. J., Saah, T. C., Dunlop, B. W., & McDonald, W. M. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.02.025 · Cited by 70 · see citing works
Doherty, T., Wajs, E., Melkote, R., Miller, J., Singh, J. B., & Weber, M. A. (2020) · CNS Drugs · doi:10.1007/s40263-020-00699-4 · Cited by 68 · see citing works
McIntyre, R. S., Lipsitz, O., Rodrigues, N. B., Lee, Y., Cha, D. S., Vinberg, M., Lin, K., Malhi, G. S., Subramaniapillai, M., Kratiuk, K., et al. (2020) · Bipolar Disorders · doi:10.1111/bdi.12941 · Cited by 66 · see citing works
Self-citationZhang, M. W., Harris, K. M., & Ho, R. (2016) · BMC Medical Ethics · doi:10.1186/s12910-016-0087-3 · Cited by 65 · see citing works
Self-citationMcIntyre, R. S., Millson, B., & Power, G. S. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.07.045 · Cited by 60 · see citing works
Self-citationCosti, S., Soleimani, L., Glasgow, A., Brallier, J., Spivack, J., Schwartz, J., Levitch, C. F., Richards, S., Hoch, M., Stade, E. C., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0365-0 · Cited by 56 · see citing works
Self-citationGrabski, M., Borissova, A., Marsh, B., Morgan, C. J. A., & Curran, H. V. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112629 · Cited by 55 · see citing works
Mathew, S. J., Wilkinson, S. T., Altinay, M. I., Asghar‐Ali, A. A., Chang, L. C., Collins, K. A., Dale, R. M., Hu, B., Krishnan, K., Kellner, C. H., et al. (2018) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.12.009 · Cited by 54 · see citing works
Self-citationAre we repeating mistakes of the past? A review of the evidence for esketamine
Horowitz, M. A., & Moncrieff, J. (2021) · The British Journal of Psychiatry · doi:10.1192/bjp.2020.89 · Cited by 53 · see citing works
The Influence of Anesthetic Agents on Rat Hepatic Cytochromes P450 in vivo
Loch, J. M., Potter, J., & Bachmann, K. A. (2008) · Pharmacology · doi:10.1159/000139276 · Cited by 52 · see citing works
Rodrigues, N. B., McIntyre, R. S., Lipsitz, O., Lee, Y. L., Cha, D. S., Nasri, F., Gill, H., Lui, L. M. W., Subramaniapillai, M., Kratiuk, K., et al. (2020) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2020.1776699 · Cited by 51 · see citing works
Self-citationRoss, E. L., & Soeteman, D. I. (2020) · Psychiatric Services · doi:10.1176/appi.ps.201900625 · Cited by 51 · see citing works
Genitourinary toxicity of ketamine
Wei, Y., Yang, J., Yin, Z., Guo, Q., Liang, B., & Zhou, K.-Q. (2013) · Hong Kong Medical Journal · doi:10.12809/hkmj134013 · Cited by 51 · see citing works
Salloum, N. C., D, M. F. M., Freeman, M. P., Flynn, M., Hoeppner, B. B., Hock, R. S., Cusin, C., Iosifescu, D. V., Trivedi, M. H., Sanacora, G., et al. (2018) · Depression and Anxiety · doi:10.1002/da.22875 · Cited by 50 · see citing works
Self-citationKetamine for Depression, 5: Potential Pharmacokinetic and Pharmacodynamic Drug Interactions
Andrade, C. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17f11802 · Cited by 48 · see citing works
Can a Framework Be Established for the Safe Use of Ketamine?
Freedman, R., Brown, A. S., Cannon, T. D., Druss, B. G., Earls, F. J., Escobar, J. I., Hurd, Y. L., Lewis, D. A., López‐Jaramillo, C., Luby, J. L., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18030290 · Cited by 47 · see citing works
Self-citationCarter, B., Strawbridge, R., Husain, M. I., Jones, B. D. M., Short, R., Cleare, A. J., Tsapekos, D., Patrick, F., Marwood, L., Taylor, R. W., et al. (2020) · International Review of Psychiatry · doi:10.1080/09540261.2020.1765748 · Cited by 47 · see citing works
Self-citationGenome-wide association study and polygenic risk score analysis of esketamine treatment response
Li, Q. S., Wajs, E., Ochs-Ross, R., Singh, J. B., & Drevets, W. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-69291-6 · Cited by 47 · see citing works
Body Mass Index as a Moderator of Treatment Response to Ketamine for Major Depressive Disorder
Freeman, M. P., Hock, R. S., Papakostas, G. I., Judge, H., Cusin, C., Mathew, S. J., Sanacora, G., Iosifescu, D. V., DeBattista, C., Trivedi, M. H., et al. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001209 · Cited by 44 · see citing works
Self-citationAlbott, C. S., Shiroma, P. R., Cullen, K. R., Johns, B., Thuras, P., Wels, J., & Lim, K. O. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16l11277 · Cited by 42 · see citing works
Successful Use of Ketamine for the Treatment of Psychotic Depression in a Teenager
Zarrinnegar, P., Kothari, J. S., & Cheng, K. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2019.0028 · Cited by 41 · see citing works
Lipsitz, O., Di Vincenzo, J. D., Rodrigues, N. B., Cha, D. S., Lee, Y., Greenberg, D., Teopiz, K. M., Ho, R. C., Cao, B., Lin, K., et al. (2021) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.12.032 · Cited by 40 · see citing works
Self-citationInfluence of urethane and ketamine on rat hepatic cytochrome P450 in vivo
Meneguz, A., Fortuna, S., Lorenzini, P., & Volpe, M. T. (1999) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(99)80027-x · Cited by 40 · see citing works
Szarmach, J., Cubała, W. J., Włodarczyk, A., & Wiglusz, M. S. (2019) · PubMed · Cited by 38 · see citing works
Neurobiological biomarkers of response to ketamine
Kadriu, B., Ballard, E. D., Henter, I. D., Murata, S., Gerlus, N., & Zarate, C. A. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.05.003 · Cited by 36 · see citing works
Self-citationEfficacy of Esketamine in the Treatment of Depression With Psychotic Features: A Case Series
Ajub, E., & Lacerda, A. L. T. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.06.011 · Cited by 35 · see citing works
The Use of Ketamine for the Treatment of Depression in the Context of Psychotic Symptoms
Ribeiro, C. M. D. F., Sanacora, G., Hoffman, R. E., & Ostroff, R. B. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.016 · Cited by 34 · see citing works
Self-citationSalloum, N. C., D, M. F. M., Hock, R. S., Freeman, M. P., Flynn, M., Hoeppner, B. B., Cusin, C., Iosifescu, D. V., Trivedi, M. H., Sanacora, G., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.09.017 · Cited by 34 · see citing works
Self-citationDold, M., Bartova, L., & Kasper, S. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa034 · Cited by 34 · see citing works
Self-citationNg, J., Lui, L. M. W., Rosenblat, J. D., Teopiz, K. M., Lipsitz, O., Cha, D. S., Xiong, J., Nasri, F., Lee, Y. L., Kratiuk, K., et al. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05767-1 · Cited by 34 · see citing works
Self-citationRapid acting antidepressants in the mTOR pathway: Current evidence
Athira, K. V., Mohan, A. S., & Chakravarty, S. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.07.022 · Cited by 33 · see citing works
Ketamine for Treatment-Resistant Depression
Zarate Jr, C. A., & Mathew, S. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-42925-0 · Cited by 31 · see citing works
Kheirabadi, D., Kheirabadi, G., Vafaie, M., Mirlouhi, Z., & Hajiannasab, R. (2019) · Advanced Biomedical Research · doi:10.4103/abr.abr_166_18 · Cited by 31 · see citing works
Ketamine and Psychosis History: Antidepressant Efficacy and Psychotomimetic Effects Postinfusion
Pennybaker, S. J., Luckenbaugh, D. A., Park, L. T., Marquardt, C. A., & Zarate, C. A. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.08.041 · Cited by 31 · see citing works
Self-citationOral Ketamine for Depression, 1
Andrade, C. (2019) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19f12820 · Cited by 30 · see citing works
Narita, M., Hashimoto, K., Amano, T., Narita, M., Niikura, K., Nakamura, A., & Suzuki, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05059.x · Cited by 29 · see citing works
Urothelial toxicity of esketamine in the treatment of depression
Findeis, H., Sauer, C., Cleare, A. J., Bauer, M., & Ritter, P. S. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05611-y · Cited by 29 · see citing works
Canuso, C. M., Singh, J. B., Fedgchin, M. M., Alphs, L. D., Lane, R., Lim, P., Pinter, C., Hough, D. W., Sanacora, G., Manji, H. K., et al. (2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.17105 · Cited by 28 · see citing works
Self-citationBenzodiazepines may reduce the effectiveness of ketamine in the treatment of depression
Ford, N., Ludbrook, G., & Galletly, C. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415590631 · Cited by 23 · see citing works
Phillips, J. L., Jaworska, N., Kamler, E., Bhat, V., Blier, J., Foster, J. A., Hassel, S., Ho, K. T., McMurray, L., Milev, R. V., et al. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02672-3 · Cited by 23 · see citing works
Lipsitz, O., McIntyre, R. S., Rodrigues, N. B., Lee, Y. L., Gill, H., Subramaniapillai, M., Kratiuk, K., Nasri, F., Mansur, R. B., & Rosenblat, J. D. (2020) · CNS Spectrums · doi:10.1017/s1092852920002102 · Cited by 23 · see citing works
Self-citationKatz, R., Toprak, M., Wilkinson, S. T., Sanacora, G., & Ostroff, R. B. (2018) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2018.05.007 · Cited by 23 · see citing works
Self-citationChen, Q., Dong, J., Luo, J., Ren, L., Min, S., Hao, X., Luo, Q., Chen, J., & Li, X. (2020) · Journal of Ect · doi:10.1097/yct.0000000000000636 · Cited by 22 · see citing works
S -ketamine compared to etomidate during electroconvulsive therapy in major depression
Zavorotnyy, M., Kluge, I., Ahrens, K., Wohltmann, T., Köhnlein, B., Dietsche, P., Dannlowski, U., Kircher, T. T. J., & Konrad, C. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0800-3 · Cited by 21 · see citing works
Schatzberg, A. F. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19030273 · Cited by 21 · see citing works
Maintaining Rapid Antidepressant Effects Following Ketamine Infusion
Papakostas, G. I. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19r12859 · Cited by 20 · see citing works
Self-citationSingh, B., Bobo, W. V., Rasmussen, K. G., Stoppel, C. J., Rico, J. A. Q., Schak, K. M., Biernacka, J. M., Frye, M. A., & Voort, J. L. V. (2019) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19l12852 · Cited by 20 · see citing works
George, M. S. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18070800 · Cited by 19 · see citing works
Chan, L. F., Eu, C. L., Soh, S. Y., Maniam, T., Kadir, Z. S., Chong, B. T. W., Loo, J. L., Sharip, S., WONG, V. C. W., Loo, T. H., et al. (2018) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000316 · Cited by 19 · see citing works
Heifets, B. D., Williams, N., Bentzley, B. S., & Schatzberg, A. F. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.0766 · Cited by 17 · see citing works
Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation
Rodrigues, N. B., Siegel, A., Lipsitz, O., Cha, D. S., Gill, H., Nasri, F., Simonson, K., Shekotikhina, M., Lee, Y., Subramaniapillai, M., et al. (2022) · CNS Spectrums · doi:10.1017/s1092852920002187 · Cited by 17 · see citing works
Self-citationSingh, J. B., Fedgchin, M. M., Daly, E., & Drevets, W. C. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.05.002 · Cited by 16 · see citing works
Rapid antidepressant effect of S-ketamine in schizophrenia
Bartova, L., Papageorgiou, K., Milenković, I., Dold, M., Weidenauer, A., Willeit, M., Winkler, D., & Kasper, S. F. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.05.007 · Cited by 16 · see citing works
Self-citationNew medications for treatment-resistant depression: a brief review of recent developments
Thase, M. E. (2017) · CNS Spectrums · doi:10.1017/s1092852917000876 · Cited by 15 · see citing works
Self-citationWang, J. C. C., & Swainson, J. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001244 · Cited by 14 · see citing works
Lin, F., He, Y., Zhang, L., Zhang, M., Zhang, Y., & Wen, C. (2015) · Europe PMC (PubMed Central) · Cited by 12 · see citing works
Opioid Receptor μ-1 and Ketamine Effects in a Suicidal Depression Trial
Grunebaum, M. F., Galfalvy, H., Liu, J., Huang, Y., Marcott, S., Burke, A. K., & Mann, J. J. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001237 · Cited by 11 · see citing works
Tratamientos disruptivos en psiquiatría
Vieta, E. (2019) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2019.10.001 · Cited by 10 · see citing works
Self-citationLi, K., & Loshak, H. (2019) · Europe PMC (PubMed Central) · Cited by 10 · see citing works
The use of ketamine in electroconvulsive therapy
Kucia, K. A., & Merk, W. (2015) · Psychiatria Polska · doi:10.12740/pp/31748 · Cited by 9 · see citing works
More Thoughts on Intranasal Esketamine: Response to Drevets et al.
Schatzberg, A. F. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19070688r · Cited by 7 · see citing works
Disruptive treatments in psychiatry
Vieta, E. (2019) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2019.10.003 · Cited by 6 · see citing works
Self-citationLetter to BJPsych in response to Horowitz and Moncrieff
Kasper, S. F., Young, A. H., Vieta, E., Goodwin, G., & Meyer‐Lindenberg, A. (2021) · The British Journal of Psychiatry · doi:10.1192/bjp.2021.161 · Cited by 2 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 12
- Toljan K, 2018, Med Sci (Basel), 6, 82
- Lin F, 2015, Int J Clin Exp Med, 8, 4335
- Szarmach J, 2019, Psychiatr Danub, 31, 585
- Andrade C, 2019, J Clin Psychiatry, 80, 19f12820
- Canuso CM, 2019, Focus Am Psychiatr Publ, 17, 55
- Wei YB, 2013, Hong Kong Med J, 19, 341
- Morgan CJA, 2004, Psychopharmacology (Berl), 172, 298
- Health Quality Ontario, 2016, Ont Health Technol Assess Ser, 16, 1
- Rodrigues NB, CNS Spectr
- Ng J, Psychopharmacology (Berl)
- Rodrigues NB, CNS Spectr
- Lipsitz O, CNS Spectr
Cited by
Sorted by citations
McIntyre, R. S., Alsuwaidan, M., Baune, B. T., Berk, M., Demyttenaere, K., Goldberg, J. F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S. H., et al. (2023) · World Psychiatry · doi:10.1002/wps.21120 · Cited by 836 · see citing works
Self-citationGukasyan, N., Davis, A. K., Barrett, F. S., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., & Griffiths, R. R. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211073759 · Cited by 425 · see citing works
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
Anand, A., Mathew, S. J., Sanacora, G., Murrough, J. W., Goes, F. S., Altinay, M. I., Aloysi, A. S., Asghar‐Ali, A. A., Barnett, B. S., Chang, L. C., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2302399 · Cited by 288 · see citing works
Self-citationAlnefeesi, Y., Chen-Li, D., Krane, E., Jawad, M. Y., Rodrigues, N. B., Ceban, F., Di Vincenzo, J. D., Meshkat, S., Ho, R. C. M., Gill, H., et al. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.04.037 · Cited by 186 · see citing works
Self-citationAbbar, M., Demattei, C., El-Hage, W., Llorca, P.-M., Samalin, L., Demaricourt, P., Gaillard, R., Courtet, P., Vaiva, G., Gorwood, P., et al. (2022) · BMJ · doi:10.1136/bmj-2021-067194 · Cited by 181 · see citing works
Self-citationMcIntyre, R. S., Alda, M., Baldessarini, R. J., Bauer, M., Berk, M., Correll, C. U., Fagiolini, A., Fountoulakis, K., Frye, M. A., Grunze, H., et al. (2022) · World Psychiatry · doi:10.1002/wps.20997 · Cited by 171 · see citing works
Self-citationKetamine Treatment for Depression: A Review
Yavi, M., Lee, H., Henter, I. D., Park, L. T., & Zarate, C. A. (2022) · Discover Mental Health · doi:10.1007/s44192-022-00012-3 · Cited by 161 · see citing works
Self-citationMartinotti, G., Vita, A., Fagiolini, A., Maina, G., Bertolino, A., Dell'Osso, B., Siracusano, A., Clerici, M., Bellomo, A., Sani, G., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.09.043 · Cited by 146 · see citing works
Self-citationRhee, T. G., Shim, S. R., Forester, B. P., Nierenberg, A. A., McIntyre, R. S., Papakostas, G. I., Krystal, J. H., Sanacora, G., & Wilkinson, S. T. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.3352 · Cited by 141 · see citing works
Self-citationNovel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status
Henter, I. D., Park, L. T., & Zarate, C. A. (2021) · CNS Drugs · doi:10.1007/s40263-021-00816-x · Cited by 142 · see citing works
Self-citationAccelerated TMS - moving quickly into the future of depression treatment
van Rooij, S. J. H., Arulpragasam, A. R., McDonald, W. M., & Philip, N. S. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01599-z · Cited by 139 · see citing works
History repeating: guidelines to address common problems in psychedelic science
van Elk, M., & Fried, E. I. (2023) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253231198466 · Cited by 137 · see citing works
Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression
Ling, S., Ceban, F., Lui, L. M. W., Lee, Y., Teopiz, K. M., Rodrigues, N. B., Lipsitz, O., Gill, H., Subramaniapillai, M., Mansur, R. B., et al. (2022) · CNS Drugs · doi:10.1007/s40263-021-00877-y · Cited by 127 · see citing works
Self-citationJha, M. K., & Mathew, S. J. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230025 · Cited by 117 · see citing works
Psychotropic Drug–Related Weight Gain and Its Treatment
McIntyre, R. S., Kwan, A. T. H., Rosenblat, J. D., Teopiz, K. M., & Mansur, R. B. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230922 · Cited by 119 · see citing works
Self-citationKetamine in neuropsychiatric disorders: an update
Johnston, J. N., Kadriu, B., Kraus, C., Henter, I. D., & Zarate, C. A. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-023-01632-1 · Cited by 108 · see citing works
Self-citationCeban, F., Rosenblat, J. D., Kratiuk, K., Lee, Y. L., Rodrigues, N. B., Gill, H., Subramaniapillai, M., Nasri, F., Lui, L. M. W., Lipsitz, O., et al. (2021) · CNS Drugs · doi:10.1007/s40263-021-00846-5 · Cited by 98 · see citing works
Self-citationRandomized trial of ketamine masked by surgical anesthesia in patients with depression
Lii, T. R., Smith, A. E., Flohr, J. R., Okada, R. L., Nyongesa, C. A., Cianfichi, L. J., Hack, L. M., Schatzberg, A. F., & Heifets, B. D. (2023) · Nature Mental Health · doi:10.1038/s44220-023-00140-x · Cited by 118 · see citing works
Han, C., Ji, H., Guo, Y., Fei, Y., Wang, C., Yuan, Y., Ruan, Z., & Ma, T. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s401161 · Cited by 92 · see citing works
Perspectives for therapy of treatment‐resistant depression
Papp, M., Cubała, W. J., Święcicki, Ł., Newman‐Tancredi, A., & Willner, P. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15596 · Cited by 92 · see citing works
The abuse liability of ketamine: A scoping review of preclinical and clinical studies
Le, T. T., Cordero, I. P., Jawad, M. Y., Swainson, J., Vincenzo, J. D. D., Jaberi, S., Phan, L., Lui, L. M. W., Ho, R., Rosenblat, J. D., et al. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.04.035 · Cited by 84 · see citing works
Self-citationPrice, R. B., Kissel, N., Baumeister, A., Rohac, R., Woody, M. L., Ballard, E. D., Zarate, C. A., Deakin, W., Abdallah, C. G., Feder, A., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01757-7 · Cited by 82 · see citing works
Self-citationThe Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Zaretsky, T. G., Jagodnik, K. M., Barsic, R., Antonio, J. H., Bonanno, P. A., MacLeod, C., Pierce, C., Carney, H., Morrison, M. T., Saylor, C. F., et al. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666231027111147 · Cited by 85 · see citing works
Martinotti, G., Dell’Osso, B. M., Lorenzo, G. D., Maina, G., Bertolino, A., Clerici, M., Barlati, S., Rosso, G., Nicola, M. D., Marcatili, M., et al. (2023) · Bipolar Disorders · doi:10.1111/bdi.13296 · Cited by 79 · see citing works
Self-citationMedeiros, G. C., Gould, T. D., Prueitt, W. L., Nanavati, J., Grunebaum, M. F., Farber, N. B., Singh, B., Selvaraj, S., Machado-Vieira, R., Achtyes, E. D., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01652-1 · Cited by 75 · see citing works
Self-citationTreatment-resistant depression: molecular mechanisms and management
Kajumba, M. M., Kakooza‐Mwesige, A., Nakasujja, N., Attix, D. K., & Canli, T. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00205-y · Cited by 86 · see citing works
Meshkat, S., Alnefeesi, Y., Jawad, M. Y., Vincenzo, J. D. D., Rodrigues, N. B., Ceban, F., Lui, L. M. W., McIntyre, R. S., & Rosenblat, J. D. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114857 · Cited by 71 · see citing works
Self-citationTherapeutic mechanisms of psychedelics and entactogens
Heifets, B. D., & Olson, D. E. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01666-5 · Cited by 67 · see citing works
Huang, J., Huang, W., Yi, J., Deng, Y., Li, R., Chen, J., Shi, J., Qiu, Y., Wang, T., Chen, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43150-0 · Cited by 74 · see citing works
Glutamatergic Modulators for Major Depression from Theory to Clinical Use
McIntyre, R. S., & Jain, R. (2024) · CNS Drugs · doi:10.1007/s40263-024-01114-y · Cited by 69 · see citing works
Self-citationXu, L., Wang, C., Deng, C.-M., Dai, S., Zhou, Q. Y., Peng, Y., Shou, H., Han, Y., Yu, J., Liu, C.-H., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.9321 · Cited by 69 · see citing works
RetractedWang, S., Deng, C.-M., Zeng, Y., Chen, X., Li, A.-Y., Feng, S., Xu, L., Chen, L., Yuan, H., Hu, H., et al. (2024) · BMJ · doi:10.1136/bmj-2023-078218 · Cited by 69 · see citing works
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions
Fagan, H. A., & Baldwin, D. S. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2211767 · Cited by 68 · see citing works
Glue, P., Loo, C. K. A., Fam, J., Lane, H., Young, A. H., Surman, P., BEDROC study investigators, Glozier, N., Fitzgerald, P. B., Liu, D., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03063-x · Cited by 65 · see citing works
Self-citationKetamine as a therapeutic agent for depression and pain: mechanisms and evidence
Subramanian, S., Haroutounian, S., Palanca, B. J. A., & Lenze, E. J. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120152 · Cited by 68 · see citing works
Page, C. E., Epperson, C. N., Novick, A. M., Duffy, K. A., & Thompson, S. M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02625-2 · Cited by 80 · see citing works
Toward Synergies of Ketamine and Psychotherapy
Mathai, D. S., Mora, V., & Garcia‐Romeu, A. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.868103 · Cited by 61 · see citing works
Seo, M. K., Jeong, S., Seog, D., Lee, J. A., Lee, J.-H., Lee, Y. L., McIntyre, R. S., Park, S. W., & Lee, J. G. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.12.089 · Cited by 61 · see citing works
Self-citationLullau, A. P. M., Haga, E. M. W., Ronold, E. H., & Dwyer, G. E. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1223145 · Cited by 63 · see citing works
Treatment-Resistant Bipolar Depression: Therapeutic Trends, Challenges and Future Directions
Elsayed, O. H., Ercis, M., Pahwa, M., & Singh, B. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s273503 · Cited by 67 · see citing works
Pettorruso, M., Guidotti, R., d’Andrea, G., Risio, L. D., D’Andrea, A., Chiappini, S., Carullo, R., Barlati, S., Zanardi, R., Rosso, G., et al. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115378 · Cited by 60 · see citing works
Self-citationKetamine and esketamine in suicidal thoughts and behaviors: a systematic review
Jollant, F., Colle, R., Nguyen, T. M. L., Corruble, E., Gardier, A. M., Walter, M., Abbar, M., & Wagner, G. (2023) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253231151327 · Cited by 56 · see citing works
Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review
Keeler, J. L., Treasure, J. L., Juruena, M. F., Kan, C., & Himmerich, H. (2021) · Nutrients · doi:10.3390/nu13114158 · Cited by 56 · see citing works
Whittaker, E., Dadabayev, A. R., Joshi, S. A., & Glue, P. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211056743 · Cited by 56 · see citing works
Levinstein, M. R., Budinich, R. C., Bonaventura, J., Schatzberg, A. F., Zarate, C. A., & Michaelides, M. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20240378 · Cited by 56 · see citing works
Self-citationNogo, D., Jasrai, A. K., Kim, H., Nasri, F., Ceban, F., Lui, L. M. W., Rosenblat, J. D., Vinberg, M., Ho, R., & McIntyre, R. S. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06105-9 · Cited by 54 · see citing works
Self-citationHashimoto, K. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01770-7 · Cited by 54 · see citing works
Levinstein, M. R., Carlton, M. L., Ianni, T. D., Ventriglia, E. N., Rizzo, A., Gomez, J. L., Budinich, R. C., Shaham, Y., Airan, R. D., Zarate, C. A., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.12.019 · Cited by 51 · see citing works
Self-citationd’Andrea, G., Pettorruso, M., Lorenzo, G. D., Rhee, T. G., Chiappini, S., Carullo, R., Barlati, S., Zanardi, R., Rosso, G., Nicola, M. D., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.12.038 · Cited by 53 · see citing works
Self-citationFeeney, A., & Papakostas, G. I. (2023) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2023.02.003 · Cited by 54 · see citing works
Self-citationChiappini, S., d’Andrea, G., Filippis, S. D., Nicola, M. D., Andriola, I., Bassetti, R., Barlati, S., Pettorruso, M., Sensi, S. L., Clerici, M., et al. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.04.011 · Cited by 52 · see citing works
Madore, M. R., Kozel, F. A., Williams, L. M., Green, L. C., George, M. S., Holtzheimer, P. E., Yesavage, J. A., & Philip, N. S. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.10.025 · Cited by 50 · see citing works
Active mechanisms of ketamine-assisted psychotherapy: A systematic review
Joneborg, I., Lee, Y. L., Vincenzo, J. D. D., Ceban, F., Meshkat, S., Lui, L. M. W., Fancy, F., Rosenblat, J. D., & McIntyre, R. S. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.07.030 · Cited by 48 · see citing works
Self-citationd’Andrea, G., Pettorruso, M., Lorenzo, G. D., Mancusi, G., McIntyre, R. S., & Martinotti, G. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.02.010 · Cited by 48 · see citing works
Self-citationThe Role of Ketamine in the Treatment of Bipolar Depression: A Scoping Review
Jawad, M. Y., Qasim, S., Ni, M., Guo, Z., Vincenzo, J. D. D., d’Andrea, G., Tabassum, A., Mckenzie, A., Badulescu, S., Grande, I., et al. (2023) · Brain Sciences · doi:10.3390/brainsci13060909 · Cited by 50 · see citing works
Self-citationBreeksema, J. J., Niemeijer, A. R., Kuin, B., Veraart, J. K. E., Kamphuis, J., Schimmel, N., van den Brink, W., Vermetten, E. H. G. J. M., & Schoevers, R. A. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.948115 · Cited by 47 · see citing works
Van Amsterdam, J., & Van Den Brink, W. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1949454 · Cited by 44 · see citing works
Swainson, J., Klassen, L. J., Brennan, S., Chokka, P. R., Katzman, M. A., Tanguay, R. L., & Khullar, A. (2022) · CNS Drugs · doi:10.1007/s40263-022-00897-2 · Cited by 47 · see citing works
Medeiros, G. C., Matheson, M., Demo, I., Reid, M. J., Matheson, S., Twose, C., Smith, G. S., Gould, T. D., Zarate, C. A., Barrett, F. S., et al. (2023) · The Lancet Psychiatry · doi:10.1016/s2215-0366(23)00183-9 · Cited by 49 · see citing works
Self-citationKetamine, an Old–New Drug: Uses and Abuses
Vujović, K. S., Jotic, A. D., Medić, B., Srebro, D., Vujović, A., Žujović, J. T., Opanković, A., & Vuckovic, S. M. (2023) · Pharmaceuticals · doi:10.3390/ph17010016 · Cited by 45 · see citing works
Brini, S., Brudasca, N. I., Hodkinson, A., Kaluzinska, K., Wach, A., Storman, D., Prokop-Dorner, A., Jemioło, P., & Bala, M. M. (2023) · Clinical Psychology Review · doi:10.1016/j.cpr.2022.102236 · Cited by 44 · see citing works
Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review
Lazur, J., Hnatyk, K., Kała, K., Sułkowska‐Ziaja, K., & Muszyńska, B. (2023) · Antioxidants · doi:10.3390/antiox12030623 · Cited by 44 · see citing works
d’Andrea, G., Chiappini, S., McIntyre, R. S., Stefanelli, G., Carullo, R., Andriola, I., Zanardi, R., Martiadis, V., Sensi, S. L., Sani, G., et al. (2023) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2023.06.016 · Cited by 41 · see citing works
Self-citationStrategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
McMullen, E. P., Lee, Y. L., Lipsitz, O., Lui, L. M. W., Vinberg, M., Ho, R., Rodrigues, N. B., Rosenblat, J. D., Cao, B., Gill, H., et al. (2021) · Advances in Therapy · doi:10.1007/s12325-021-01732-8 · Cited by 44 · see citing works
Self-citationReal‐world effectiveness of repeated ketamine infusions for treatment‐resistant bipolar depression
Fancy, F., Rodrigues, N. B., Di Vincenzo, J. D., Chau, E. H., Sethi, R., Husain, M. I., Gill, H., Tabassum, A., Mckenzie, A., Phan, L., et al. (2023) · Bipolar Disorders · doi:10.1111/bdi.13284 · Cited by 40 · see citing works
Self-citationLi, Q., Wang, S., & Mei, X. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114396 · Cited by 38 · see citing works
Psiuk, D., Nowak, E., Dycha, N., Łopuszańska, U., Kurzepa, J., & Samardakiewicz, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911450 · Cited by 34 · see citing works
Danayan, K., Chisamore, N., Rodrigues, N. B., Vincenzo, J. D. D., Meshkat, S., Doyle, Z., Mansur, R. B., Phan, L., Fancy, F., Chau, E. H., et al. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115133 · Cited by 38 · see citing works
Self-citationThe Economics of Treatment for Depression
Stecher, C. D., Cloonan, S., & Domino, M. E. (2023) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-061022-040533 · Cited by 42 · see citing works
Akbar, D., Rhee, T. G., Ceban, F., Ho, R., Teopiz, K. M., Cao, B., Subramaniapillai, M., Kwan, A. T. H., Rosenblat, J. D., & McIntyre, R. S. (2023) · CNS Drugs · doi:10.1007/s40263-023-01032-5 · Cited by 38 · see citing works
Self-citationVincenzo, M. D., Martiadis, V., Rocca, B. D., Arsenio, E., D’Arpa, A., Volpicelli, A., Luciano, M., Sampogna, G., & Fiorillo, A. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1394787 · Cited by 37 · see citing works
A pilot randomized controlled trial of ketamine in Borderline Personality Disorder
Fineberg, S. K., Choi, E. Y., Shapiro-Thompson, R., Dhaliwal, K., Neustadter, E. S., Sakheim, M., Null, K. E., Diaz, D. T., Rondeau, J. A., Pittaro, G. F., et al. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01540-4 · Cited by 41 · see citing works
Recent advances in the study of anesthesia-and analgesia-related mechanisms of S-ketamine
Zhou, J., Peng, G., Liang, W., Chen, Z., Liu, Y., Wang, B., Guo, M., Deng, Y.-L., Jun-ming, Y., Zhong, M., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1228895 · Cited by 39 · see citing works
Sex dependence of opioid-mediated responses to subanesthetic ketamine in rats
Ianni, T. D., Ewbank, S. N., Levinstein, M. R., Azadian, M. M., Budinich, R. C., Michaelides, M., & Airan, R. D. (2024) · Nature Communications · doi:10.1038/s41467-024-45157-7 · Cited by 33 · see citing works
Pharmacogenomics of ketamine: A systematic review
Meshkat, S., Rodrigues, N. B., Vincenzo, J. D. D., Ceban, F., Jaberi, S., McIntyre, R. S., Lui, L. M. W., & Rosenblat, J. D. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.11.036 · Cited by 36 · see citing works
Self-citationRodolico, A., Cutrufelli, P., Francesco, A. D., Aguglia, A., Catania, G., Concerto, C., Cuomo, A., Fagiolini, A. M., Lanza, G., Mineo, L., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1325399 · Cited by 35 · see citing works
de la Salle, S., Phillips, J. L., Blier, P., & Knott, V. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110507 · Cited by 36 · see citing works
Ledesma‐Corvi, S., Hernández‐Hernández, E., & García-Fuster, M. J. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01994-y · Cited by 33 · see citing works
Hietamies, T. M., McInnes, L. A., Klise, A., Worley, M. J., Qian, J. J., Williams, L. M., Heifets, B. D., & Levine, S. P. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.04.141 · Cited by 33 · see citing works
Calder, C. N., Kwan, A. T. H., Teopiz, K. M., Wong, S., Rosenblat, J. D., Mansur, R. B., Rhee, T. G., Ho, R., Cao, B., & McIntyre, R. S. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.04.039 · Cited by 35 · see citing works
Self-citationAn Astroglial Basis of Major Depressive Disorder: Molecular, Cellular, and Circuit Features
Lu, C., Ren, J., & Cao, X. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.07.017 · Cited by 33 · see citing works
McIntyre, R. S., Rosenblat, J. D., Rodrigues, N. B., Lipsitz, O., Chen-Li, D. C. J., Lee, J. G., Nasri, F., Subramaniapillai, M., Kratiuk, K., Wang, A., et al. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113993 · Cited by 33 · see citing works
Self-citationWen, Y., Mao, M., Wang, X., Xu, C., Shi, X., Li, P., Tian, Z., Jiang, M., Yuan, H., & Feng, S. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115765 · Cited by 32 · see citing works
McIntyre, R. S., Kwan, A. T. H., Mansur, R. B., Oliveira-Maia, A. J., Teopiz, K. M., Maletic, V., Suppes, T. M., Stahl, S. M., & Rosenblat, J. D. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230902 · Cited by 32 · see citing works
Self-citationThe therapeutic role of ketamine and esketamine in treating psychopathological domains of depression
Jawad, M. Y., Vincenzo, J. D. D., Badulescu, S., Teopiz, K. M., Tabassum, A., Ceban, F., Mckenzie, A., Meshkat, S., Rosenblat, J. D., Ho, R., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109299 · Cited by 32 · see citing works
Self-citationGoldfine, C. E., Tom, J. J., Im, D. D., Yudkoff, B., Anand, A., Taylor, J. J., Chai, P. R., & Suzuki, J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1141836 · Cited by 32 · see citing works
Garel, N., Lévesque, J. T., Sandra, D. A., Lessard-Wajcer, J., Solomonova, E., Lifshitz, M., Richard‐Devantoy, S., & Greenway, K. T. (2023) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1200393 · Cited by 31 · see citing works
Wang, H., Wang, L., Gao, J., & Zhou, F. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-05787-y · Cited by 31 · see citing works
Guo, H., Wang, B., Yuan, S., Wu, S., Liu, J., He, M., & Wang, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.849758 · Cited by 31 · see citing works
Garel, N., McAnulty, C., Greenway, K. T., Lespérance, P., Miron, J., Rej, S., Richard‐Devantoy, S., & Jutras‐Aswad, D. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109606 · Cited by 32 · see citing works
The Quest for Secondary Pharmaceuticals: Drug Repurposing/Chiral-Switches Combination Strategy
D’Acquarica, I., & Agranat, I. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.2c00151 · Cited by 33 · see citing works
Pharmacologic approaches to suicide prevention
Zisook, S., Domingues, I., & Compton, J. (2023) · Focus · doi:10.1176/appi.focus.20220076 · Cited by 30 · see citing works
Biomarkers of ketamine’s antidepressant effect: An umbrella review
Meshkat, S., Ho, R. C., Cao, B., Teopiz, K. M., Rosenblat, J. D., Rhee, T. G., Di Vincenzo, J. D., Ceban, F., Jawad, M. Y., & McIntyre, R. S. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.12.021 · Cited by 29 · see citing works
Self-citationJawad, M. Y., Vincenzo, J. D. D., Ceban, F., Jaberi, S., Lui, L. M. W., Gillissie, E. S., Alnefeesi, Y., Rosenblat, J. D., & McIntyre, R. S. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2058488 · Cited by 29 · see citing works
Self-citationChen, S., Yang, J.-J., Zhang, Y., Lei, L., Qiu, D., Lv, H.-M., Sun, Z., Hashimoto, K., & Yang, J. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01611-z · Cited by 30 · see citing works
History repeating: A roadmap to address common problems in psychedelic sciencePreprint
van Elk, M., & Fried, E. I. (2023) · doi:10.31234/osf.io/ak6gx · Cited by 30 · see citing works
Le, G. H., Wong, S., Badulescu, S., Au, H., Di Vincenzo, J. D., Gill, H., Phan, L., Rhee, T. G., Ho, R., Teopiz, K. M., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.03.165 · Cited by 30 · see citing works
Self-citationKetamine for bipolar depression: an updated systematic review
Fancy, F., Haikazian, S., Johnson, D. E., Chen-Li, D. C. J., Levinta, A., Husain, M. I., Mansur, R. B., & Rosenblat, J. D. (2023) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253231202723 · Cited by 29 · see citing works
Self-citationMcIntyre, R. S., Rasgon, N., Goldberg, J. F., Wong, S., Le, G. H., Mansur, R. B., Rosenblat, J. D., Teopiz, K. M., & Stahl, S. M. (2025) · CNS Spectrums · doi:10.1017/s1092852925000124 · Cited by 32 · see citing works
Self-citationKeeler, J. L., Treasure, J. L., Himmerich, H., Brendle, M., Moore, C., & Robison, R. J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1181447 · Cited by 28 · see citing works
- Authors
- McIntyre, R. S., Rosenblat, J. D., Nemeroff, C. B., Sanacora, G., Murrough, J. W., Berk, M., Brietzke, E., Dodd, S., Gorwood, P., Ho, R., Iosifescu, D. V., Lopez Jaramillo, C., Kasper, S., Kratiuk, K., Lee, J. G., Lee, Y., Lui, L. M. W., Mansur, R. B., Papakostas, G. I., Subramaniapillai, M., Thase, M., Vieta, E., Young, A. H., Zarate, C. A., & Stahl, S.
- Affiliations
- University Health Network (CA)
- Mood Disorders Psychopharmacology Unit, University Health Network, Toronto (McIntyre, Rosenblat, Y. Lee, Lui, Mansur); Department of Psychiatry, University of Toronto, Toronto (McIntyre, Rosenblat, Mansur); Department of Pharmacology, University of Toronto, Toronto (McIntyre); Brain and Cognition Discovery Foundation, Toronto (McIntyre, Subramaniapillai); Canadian Rapid Treatment Center of Excellence, Mississauga, Ontario (Rosenblat, Kratiuk); Department of Psychiatry and Behavioral Sciences, Austin Dell...
- ORCID
- McIntyre, Roger S.
- Rosenblat, Joshua D.
- Nemeroff, Charles B.
- Sanacora, Gerard
- Murrough, James W.
- Brietzke, Elisa
- Dodd, Seetal
- Gorwood, Philip
- Ho, Roger
- Iosifescu, Dan V.
- Kasper, Siegfried
- Kratiuk, Kevin
- Lee, Jung Goo
- Lee, Yena
- Lui, Leanna M.W.
- Mansur, Rodrigo B.
- Papakostas, George I.
- Subramaniapillai, Mehala
- Thase, Michael
- Vieta, Eduard
- Young, Allan H.
- Zarate, Carlos A.
- Stahl, Stephen
- Venue
- American Journal of Psychiatry
- Published
- 2021-05-01
- Volume
- 178
- Issue
- 5
- Pages
- 383-399
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- PMC
- PMC9635017
- OpenAlex
- W3137976016
- Semantic Scholar
- 3cd087ef6947b39c8c924b7248d9d40de77b9e44
- Cited by
- 731
- References
- 168
- Citations by year
- 2026: 129 · 2025: 167 · 2024: 165 · 2023: 141 · 2022: 83 · 2021: 44
- FWCI
- 13.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Wellcome Trust
- National Institute for Health and Care Research (NIHR202380)
- National Institutes of Health (Z99 MH999999)
- National Institute of Mental Health (ZIAMH002857, ZIAMH002927)
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- ketamine, esketamine, treatment-resistant depression, major depressive disorder, drug safety and tolerability, clinical implementation, treatment algorithm, expert consensus
- MeSH terms
- Implementation Science, Antidepressive Agents, Delivery of Health Care, Depressive Disorder, Major, Major Depressive Disorder, Dissociative Disorders, Humans, Hypertension, Ketamine, Monitoring, Physiologic, Personnel Staffing and Scheduling, Psychoses, Substance-Induced, Patient Selection, Excitatory Amino Acid Antagonists, Substance-Related Disorders, Suicidal Ideation, Lower Urinary Tract Symptoms, Depressive Disorder, Treatment-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
